Chemoinformaics analysis of panaxoside a progenin i
| Molecular Weight | 638.883 | nRot | 7 |
| Heavy Atom Molecular Weight | 576.387 | nRig | 27 |
| Exact Molecular Weight | 638.439 | nRing | 5 |
| Solubility: LogS | -3.441 | nHRing | 1 |
| Solubility: LogP | 3.416 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 107 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 62 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 108.679 |
| nHD | 7 | BPOL | 65.6708 |
| QED | 0.208 |
| Synth | 5.57 |
| Natural Product Likeliness | 3.012 |
| NR-PPAR-gamma | 0.042 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.917 |
| Pgp-sub | 0.018 |
| HIA | 0.927 |
| CACO-2 | -4.994 |
| MDCK | 0.0000504 |
| BBB | 0.079 |
| PPB | 0.881454 |
| VDSS | 0.845 |
| FU | 0.0690551 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.114 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.807 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.236 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.073 |
| CL | 3.983 |
| T12 | 0.033 |
| hERG | 0.038 |
| Ames | 0.042 |
| ROA | 0.316 |
| SkinSen | 0.036 |
| Carcinogencity | 0.007 |
| EI | 0.004 |
| Respiratory | 0.863 |
| NR-Aromatase | 0.397 |
| Antiviral | Yes |
| Prediction | 0.751167 |